Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.23835 | 9 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.22433 | 9 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.22705 | 9 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.17688 | 9 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.27273 | 13 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.26539 | 9 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.22181 | 8 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.20421 | 9 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.17608 | 8 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.22084 | 9 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.2069 | 9 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.19329 | 9 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.20486 | 9 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.22801 | 10 |